Daphne Quimi is Director of Century Therapeutics, Inc.. Currently has a direct ownership of 5,000 shares of IPSC, which is worth approximately $5,500. The most recent transaction as insider was on Sep 12, 2024, when has been sold 5,000 shares (Common Stock) at a price of $1.53 per share, resulting in proceeds of $7,650. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5K
0% 3M change
n/a 12M change
Total Value Held $5,500

Daphne Quimi Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 12 2024
BUY
Open market or private purchase
$7,650 $1.53 p/Share
5,000 Added 50.0%
5,000 Common Stock

Also insider at

FOLD
AMICUS THERAPEUTICS, INC. Healthcare
AMLX
Amylyx Pharmaceuticals, Inc. Healthcare
DQ

Daphne Quimi

Director
Philadelphia, PA

Track Institutional and Insider Activities on IPSC

Follow Century Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IPSC shares.

Notify only if

Insider Trading

Get notified when an Century Therapeutics, Inc. insider buys or sells IPSC shares.

Notify only if

News

Receive news related to Century Therapeutics, Inc.

Track Activities on IPSC